Clinical Trial Update: Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase II study evaluating the combination of atezolizumab and bevacizumab in endometrial cancer. The trial status is active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Oklahoma | Conditions: Endometrial Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING